ESG Data Table

Organizational Governance

Reported Items Related Data
Unit FY2021 FY2020 FY2019
Management Structure
  Executive Committee Times 11 11 11
Board of Directors Times 22 21 20
Attendance Rate of Board of Directors % 98.96 100 98.13
Directors Persons 9 8 8
Of which, Outside Directors Persons 4 3 3
Of which, Female Directors Persons 1 1 1
Amount of Remuneration and the Like Millions of Yen 392 391 378
Principal Activities of Outside Directors
Yutaka Atomi He attended all twenty-two (22) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily from the professional standpoint of a medical doctor. He attended all twenty-one (21) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily from the professional standpoint of a medical doctor. He attended all twenty (20) meetings held by the Board of Directors during the fiscal year under review.
He made statements at those meetings, primarily from the professional standpoint of a medical doctor.
Saeko Arai She attended all twenty-two (22) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on her extensive experience as a corporate executive and from the professional standpoint of a certified public accountant. She attended all twenty-one (21) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on her extensive experience as a corporate executive and from the professional standpoint of a certified public accountant. Out of the twenty (20) meetings during the fiscal year under review, she attended nineteen (19) meetings held by the Board of Directors.
She made statements at those meetings, primarily based on her extensive experience as a corporate executive and from the professional standpoint of a certified public accountant.
Nobuhiro Endo He attended all twenty (20) of the twenty-two (22) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive. He attended all twenty-one (21) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive. He attended fifteen (15) of the sixteen (16) meetings held following his appointment as a Director.
He made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive.
Minoru Usui He attended all seventeen (17) meetings held by the Board of Directors during the fiscal year under review after his assumption of office as a Director, and made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive. - -
Audit System
  Audit & Supervisory Board Times 13 13 13
Audit & Supervisory Board Members Persons 5 5 5
Of which, Outside Audit & Supervisory Board Members Persons 3 3 3
Amount of Remuneration and the like Millions of Yen 89 87 87
Full-time Staff of Corporate Audits' Office Persons 1 1 1
Principal Activities of Outside Audit Supervisory Board
Junsuke Fujii He attended all twenty-two (22) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit & Supervisory Board during the fiscal year under review.
He made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive.
He attended twenty (20) meetings out of the twenty-one (21) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit & Supervisory Board during the fiscal year under review.
He made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive.
He attended all twenty (20) meetings held by the Board of Directors and twelve (12) of the thirteen (13) Audit & Supervisory Board meetings.
He made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive.
Yoshio Iteya He attended all twenty-two (22) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit & Supervisory Board during the fiscal year under review.
He made statements at those meetings, primarily from the professional standpoint of an attorney.
He attended all twenty-one (21) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit & Supervisory Board during the fiscal year under review.
He made statements at those meetings, primarily from the professional standpoint of an attorney.
He attended nineteen (19) of the twenty (20) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit & Supervisory Board during the fiscal year under review.
He made statements at those meetings, primarily from the professional standpoint of an attorney.
Mayumi Mochizuki She attended eleven (11) meetings out of the seventeen (17) meetings held by the Board of Directors and eight (8) meetings out of the ten (10) meetings held by the Audit & Supervisory Board during the fiscal year under review after her assumption of office as an Audit & Supervisory Board Member.
She made statements at those meetings, primarily from the professional standpoint as a pharmacologist.
- -
Communication about Compliance
  Corporate CSR Blog Articles 3 6 2
Framework for Compliance Implementation
Periodic Report at Board of Directors Times Annually Annually Annually
Compliance Committee Times Annually Annually Annually
Compliance Committee of Group Companies in Japan Times Annually Annually Annually
Compliance Committee of Group Companies outside Japan Times Annually Annually Annually
Whistle-blowing Systems, Consultation Desks
Systems
for All Employees
Systems 7 7 7
Consulted Issues Cases 41 44 37
Compliance Education and Training
Compliance Trainings
for All Employees
Times Semiannually Annually Annually
Compliance Workshops Held at the Workplace Level
for All Workplaces
Times Annually Annually Annually
Compliance Workshops Held at the Group Companies
for all Group Companies
Times Annually Annually Annually
Harmful Incident Concerning Pharmaceuticals Workshops
for All Workplaces
Times Annually Annually Annually
Information Security Training
for All Employees
Times Annually Annually Annually
Stress Check
for All Employees
Times Annually Annually Annually
Mental Health Manager Workshops Times Annually Annually Annually
Mental Health Self-care Workshops Times Annually Annually Annually
Product Recall Training in Corporate Regulatory Compliance & Quality assurance Division Times 1 0 0
Natural Disaster Training in Risk Management Related Divisions Times Annually Annually Annually
R&D Ethics e-Learning
For researchers who are recommended to take the course on the job
Times Annually Annually Annually

Human Rights

Reported Items Related Data
Unit FY2021 FY2020 FY2019
Initiative to Respect Human Rights
  Human Rights Workshops
for All Employees
Times Annually Annually Semiannually
Drug-induced Suffering Workshops
for All Employees
Times Annually Annually Annually
Supply Chain Human Rights Management Workshop Times 0 0 Annually
Initiative to Prevent Harrasment
  Number of People in Charge of the General Consultation Desk Staffs 2 2 2
Number of People in Charge of the Harassment Consultation Desk (Internal Company) Staffs General Desk, 3 Staffs
Working Place Desk, 7 Sites,
17 Staffs
General Desk, 3 Staffs
Working Place Desk, 7 Sites,
17 Staffs
General Desk, 3 Staffs
Working Place Desk, 7 Sites,
17 Staffs
Number of People in Charge of the Harassment Consultation Desk (Workers Union) Staffs General Desk, 5 Staffs
Working Place Desk, 11 Sites,
11 Staffs
General Desk, 5 Staffs
Working Place Desk, 11 Sites,
11 Staffs
General Desk, 6 Staffs
Working Place Desk, 9 Sites,
9 Staffs

Labour Practices

Reported Items Related Data
Unit FY2021 FY2020 FY2019
Basic Human Resources Data
  Number of Employees (consolidated)
*As of March 31
Persons 6,987 6,822 6,457
Men Persons 4,147 4,119 3,970
Women Persons 2,840 2,703 2,487
Proportion of Women % 40.6 39.6 38.5
Number of Employees (non-consolidated)
*As of March 31
Persons 3,040 3,067 3,023
Men Persons 2,292 2,377 2,322
Women Persons 748 730 701
Proportion of Women % 24.6 23.8 23.2
Proportion of Female Managers
*As of April 1 of the following fiscal year
% 16.0 14.6 12.2
MRs in Japan, Including Managers Persons 1,220 1,270 1,340
MRs in Japan, Excluding Managers Persons 1,110 1,150 1,220
Average Age Age 43.4 43.1 42.8
Average Length of Continuous Employment Years 18.0 17.8 17.6
Recruitment of New Graduates Persons 64 66 35
Propotion of Women, New Graduates % 53.1 47.0 51.4
Recruitment of Mid Carrer Persons 29 44 37
Proportion of Recruitment of Mid Carrer % 31.2 40.0 51.4
Employment Rate of Persons with Disabilities
*As of June 1, every fiscal year
% 2.34 2.25 2.27
Employee Turnover Rate of Employees Leaving for Personal Reasons % 1.68 1.17 1.49
Retention Rate of New Graduates 3 Years after Joining the Company % 94.3 100 89.5
Workers Union Participating Rate Eligibility Conducted by Collective Agreement Article 3-1 % 100 100 100
Total Actual Working Hours per year Hours 1871.5 1862.3 1860.1
Average Overtime Hours per month Hours 4.1 3.3 3.7
Avarage Usage of Paid Leave Days
per a
Employee
14.1 13.0 15.4
Paid Leave Acquisition Rate % 70.0 64.0 74.5
Male Employees Taking Childcare Leave (note1) Persons 83 32 16
Childcare Leave Usage Rate (Male Employees) % 97.6 42.1 17.6
Female Employees Taking Childcare Leave Persons 51 33 42
Utilization of Shorter Working Hours for Childcare Persons 66 60 96
Utilization of Leave for Nursing Care Persons 1 1 1
Utilization of Shorter Workdays for Nursing Care Persons 1 2 3
Mental Illness Leave (≧30days) Persons 25 6 8
Health and Safety Management
  Stress Check
for All Employees
Times Annually Annually Annually
Mental Health Manager Workshops Times Annually Annually Annually
Mental Health Self-care Workshops Times Annually Annually Annually
No-Overtime Day at Workplace Level Days Established at Each Workplace Established at Each Workplace Established at Each Workplace
Whole Company No-Overtime Day Days 1 1 1
Work-related Accident Frequency Rate (non-consolidated Employees) (note2)
* Includes accidents with no lost workdays
- 1.27 0.80 1.32
Lost-time Injuries Frequency Rate (non-consolidated Employees) (note2) - 0.16 0.00 0.16
Work-Related Accident Frequency Rate Excluding Accidents Involving Business Vehicles (non-consolidated Employees) (note2)
* Includes accidents with no lost workdays
- 0.79 0.00 0.33
Lost-Time Injury Frequency Rate Excluding Accidents Involving Business Vehicles (non-consolidated Employees) (note2) - 0.16 0.00 0.16
Lost-time Injuries Frequency Rate (consolidated Employees) (note3) - 0.22 0.08 -
Lost-time Injuries Frequency Rate
(Employees of contractors at non-consolidated business unites)
- 1.36 0.00 0.00
Communication with Employees
  Employee Engagement Survey Times Annually Annually Annually
Response Rate % 98.8 98.8 99.0
Opinions toward Management Cases 778 1,063 1,270
Proposals Made to Address Issues and/or Offer Solutions at Respective Divisions/Departments Cases 986 1,436 1,660

note:1 The number of employees excluding seconded employees is listed.

note:2 Calculated for the Company and SMP Distribution Service Co., Ltd.

note:3 Excludes one company whose accident report was not available.

The Environment

Reported Items Related Data
Unit FY2021 FY2020 FY2019
Environmental Management
  Executive Environmental and Safety Board Times Semiannually Semiannually Semiannually
Environmental and Safety Committee Times Three Semiannually Semiannually
Environmental and Safety Audit Business units 6 4 5
Follow-up Activities for Environmental and Safety Audit Cases 16 10 7
Environmental Accidents Incidents 0 0 0
Violation of Environmental Laws and Regulations Involving Criminal or Non-Criminal Fines Incidents 0 0 0
Waste Containing High Levels of PCB in Storage Units 0 1 2,344
Waste Containing Low Levels of PCB in Storage or in Use Units 4 4 4
Input and Output
  Energy Consumption
Total Energy Consumption TJ 1,434*1 1,273 1,282
Includes Renewable Energy
Consumption of
TJ 69*1 1 1
Water Withdrawal
Total Amount of Water Withdrawal t 873,171*2 821,090 774,345
Tap Water t 397,701*2 272,538 253,832
Industrial Water t 408,387*2 393,987 289,223
Ground Water t 55,853*2 142,183 224,210
Other t 11,230*2 12,382 7,080
Raw Material Consumption
Raw Materials for Products (excluding Metals) t 3,577 3,997 5,199
Raw Materials for Products (Metals) t 0 10 11
PRTR Substances t 1,417 1,545 2,044
Product Packaging Materials t 642 665 721
Released into the Atmosphere
CO2 Emissions
Scope 1 (from Energy Sources) t-CO2 21,398*1 19,514 19,221
Scope 2 (market-based) t-CO2 40,351*1 38,753 40,056
Scope 1 (from Energy Sources) + Scope 2 (market-based) t-CO2 61,749*1 58,267 59,276
SOX t 0.3 0.2 0.3
NOX t 37.5 42.2 43.9
Dust Emissions t 0.2 0.2 0.8
PRTR Substances t 3.0 5.3 8.2
Released into Water Systems
Total Amount of Water Discharged t 866,398*2 821,090 774,345
River t 604,448*2 616,743 554,699
Sewerage t 261,950*2 204,347 219,646
BOD t 0.2 0.2 0.2
COD t 2.2 2.2 2.2
Phosphorus t 0.1 0.1 0.1
Nitrogen t 0.5 0.3 0.4
PRTR Substances t 0.0 0.0 0.0
Waste
Total Amount of Waste Generated t 6,183 7,685 9,381
Amount of Specially-Controlled Industrial Waste Generated t 5,196 6,402 8,014
Amount Recycled t 4,717 6,133 7,760
Amount of Final Disporsal t 18 56 47
PRTR Substances t 1,371 1,453 1,926
Mid-term Environmental Goal
  Atmospheric Emission Rate of PRTR Substances % 0.2 0.3 0.4
Atmospheric Emission Rate of VOC Substances % 0.7 0.7 0.6
Reduction Ratio of CO2 Emissions Compared to the FY 2017 (+ :reduction, - :increase) % +30 +23 +22
Reduction Ratio of Per-unit Energy Consumption (5-year average)
(+ :reduction, - :increase)
% +0.2 - -
Final Disposal Rate % 0.3 0.7 0.5
Waste Recycling Rate % 76 80 83
Reduction Ratio of Water withdrawal Compared to the FY 2018 (+ :reduction, - :increase) % +4 +3 +9
Environmental accounting
  Environmental Investment Millions of Yen 226.4 15.9 82.1
Environmental Expenditure Millions of Yen 772 731 1,045
Economic Effect Millions of Yen 2.8 2.8 2.3
Contributing to Building a Low-carbon Society
  ‹non-consolidated›
CO2 Emissions (Scope 1 + Scope 2)
Scope 2; market-based
t-CO2 53,116 58,267 59,276
CO2 Emissions (Scope 3) *3 t-CO2 383,644 393,973 380,001
Rate of Hybrid Vehicles Used as Sales Fleets (excluding cold regions) % 100 100 100
Amount of Generated Electricity at the Solar Power Generating Systems*4 MWh 86 89 141
‹Including consolidated subsidiaries*1
CO2 Emissions (Scope 1 + Scope 2)
Scope 2; market-based
t-CO2 61,749 - -
Total Energy Consumption TJ 1,434 - -
Includes Renewable Energy Consumption of TJ 69 - -
Effective Use of Resources
  Effective Use of Water Resources
‹non-consolidated›
Total Amount of Water Withdrawal t 814,250 821,090 774,345
Tap Water t 338,780 272,538 253,832
Industrial Water t 408,387 393,987 289,223
Ground Water t 55,853 142,183 224,210
Other t 11,230 12,382 7,080
Total Amount of Water Discharged t 814,250 821,090 774,345
River t 604,448 616,743 554,699
Sewerage t 209,802 204,347 219,646
‹Including consolidated subsidiaries*2
Total Amount of Water Withdrawal t 873,171 - -
Tap Water t 397,701 - -
Industrial Water t 408,387 - -
Ground Water t 55,853 - -
Other t 11,230 - -
Total Amount of Water Discharged t 866,398 - -
River t 604,448 - -
Sewerage t 261,950 - -
Reduction of Waste
Total Amount of Waste Generated t 6,183 7,685 9,381
Amount of Specially-Controlled Industrial Waste Generated t 5,196 6,402 8,014
Amount Recycled t 4,717 6,133 7,760
Amount of Final Disporsal % 0.3 0.7 0.5
Recycling Rate % 76 80 83
Reduction of Chemical Substance Emissions
PRTR Substances t 1,417 1,545 2,044
PRTR Substances Released into the Atmosphere t 3.0 5.3 8.2
VOC Substances t 2,452 3,215 3,797
VOC Substances Released into the Atmosphere t 17.3 22.8 22.8
Development of Environmental Conservation Systems
Green Logistics initiatives 46 67 67
Green Product Development initiatives 37 30 28
Green Facilities Design initiatives 13 15 15
Environmental Communication
  Communications with Group Companies
Meeting to Exchange Information on Environment and Safety between Group Companies in Japan Times Annually Annually Annually
Environment and Safety Audits Conducted for Group Companies in Japan companies 2 2 0
Environmental and Safety Audits Conducted for Group Companies Outside Japan companies 0 0 1
Biodiversity
  Owls Forest Restoration Project of Kishiwada City, Osaka*5 Times/
Participants
1
13
2
20
5
128

*1 : Boundary of calculation; Sumitomo Pharma Co., Ltd., consolidated subsidiaries in Japan, overseas consolidated subsidiaries' production sites (Sumitomo Pharma (Suzhou) Co., Ltd.) and their major R&D facilities (Sunovion Pharmaceuticals Inc., Sumitomo Pharma Oncology, Inc.)

*2 : Boundary of calculation; Sumitomo Pharma Co., Ltd. (not including branches and business offices), consolidated subsidiaries in Japan (not including small offices), overseas consolidated subsidiaries' production sites (Sumitomo Pharma (Suzhou) Co., Ltd.) and their major R&D facilities (Sunovion Pharmaceuticals Inc., Sumitomo Pharma Oncology, Inc.)

*3 :"CO2 emissions (Scope 3)" includes Category 2 (capital goods) CO2 emissions calculated on a consolidated basis, including overseas subsidiaries.

*4 : The volume of solar power generation in fiscal 2020 and 2021 shows only the volume of solar power generation at the Central Research Laboratories due to measuring instrument failure at the Osaka Research Center.

*5 : In fiscal 2020 and 2021, we refrained from the activities to prevent the spread of COVID-19.

Fair Operating Practices

Reported Items Related Data
Unit FY2021 FY2020 FY2019
Appropriate Information Disclosure and Management
  Information Security Training
for All Employees
Times Annually Annually Annually
Violations of Code of Conduct
  Corruption, Bribery, Discrimination and Other Malpractices Times 0 0 0

Consumer Issues

Reported Items Related Data
Unit FY2021 FY2020 FY2019
   
Initiatives to Provide Stable Supplies
  Factory in Japan Sites 2 2 2
Distribution Center in Japan Sites 2 2 2
Initiatives to Ensure Safety of Pharmaceuticals
  Product Recall Training in Corporate Regulatory Compliance & Quality Assurance Division Times 0 0 0
Harmful Incident Concerning Pharmaceuticals Workshops
for all Employees
Times Annually Annually Annually
Initiatives to Improve Access to Medicines
  Responding to Demands for Development of Unapproved or Off-Label Drugs Projects 2 1 1
Collaborative Programs with Public Institutions to Control Malaria, Influenza, and Antimicrobial Resistance (AMR) and Hepatitis B Projects 7 6 5
Fight against Counterfeit Pharmaceuticals in collaboration with international organizations Projects 1 1 2
Communication with Customers
  Inquiries to the Product Information Center Times about
34,000
about
41,500
about
36,900

Community Involvement and Development

Reported Items Related Data
Unit FY2021 FY2020 FY2019
Stakeholder Dialogue
  Dialogue with Patients and Families
Inquiries to the Product Information Center Times 1,900 3,800 1,900
Dialogue with Healthcare professionals
Inquiries to the Product Information Center Times 29,800 34,800 32,000
Dialogue with Collaboration partners
Competitive Open Innovation Program framework "PRISM" (Research Needs Presentation, Joint Creation by Young Researchers) Number of acceptance / Number of applications 2/15
1 Collaboration out of PRISM
2/15
1 Collaboration out of PRISM
4/18
2 Collaboration out of PRISM
Dialogue with Shareholders
Shareholders' Meeting Times Annually Annually Annually
Financial Results Announcement Times Semiannually Semiannually Semiannually
Conference Call Times Semiannually Semiannually Semiannually
Meeting with Analysts and Institutional Investors Times 103 76 99
ESG Meeting Times Annually Annually Annually
R&D Meeting Times Annually Annually Annually
Dialogue with Employees
Employee Engagement Survey Times Annually Annually Annually
Response Rate % 98.8 98.8 99.0
Opinions toward Management Cases 778 1,063 1,270
Proposals Made to Address Issues and/ or Offer Solutions at Respective Divisions/ Departments Cases 986 1,436 1,660
Supporting through Employee Participation
  Educational Assistance for the Next-generation
Visiting Lectures by Employees Schools 7 4 25
Biodiversity
The Owls Forest Restoration Project at the Sumitomo Pharma Forest Times 1 2 5